Oral Contraceptive Pills: Access and Availability
This brief provides an overview of oral contraception, discusses private insurance and Medicaid coverage, and reviews strategies to promote and expand women’s access to oral contraceptives.
View the Latest: Contraception
Filter
-
-
3 Charts: The Cost and Coverage of Opill—the First FDA-approved Over-the-Counter Daily Oral Contraceptive Pill in the United States
News ReleaseThe first FDA-approved over-the-counter daily oral contraceptive pill in the United States— Perrigo’s Opill— is now available for pre-order at major online retailers and will soon be available in stores.
-
Preventive Services Covered by Private Health Plans under the Affordable Care Act
Fact SheetNote: This content was updated on February 28, 2024 to incorporate new FAQs from CMS. Tables 1 and 2 were also updated to include updated recommendations. It has been more than ten years since the Affordable Care Act (ACA) required private insurance plans to cover recommended preventive services without any patient cost-sharing.
-
Want to Learn About Women’s Health in your State? Check out KFF’s Updated Interactive Dashboard
News ReleaseKFF recently updated its interactive dashboard with national and state data on women’s health, as well as information about various policies that affect women’s health.
-
Year in Review: 10 Health Policy Issues for 2023
Fact SheetThis fact sheet offers a look back at 10 issues that KFF tracked closely during 2023 in its polling, policy analysis and journalism, including summaries of major findings and news stories.
-
KFF Examines Key Considerations for the Implementation of Insurance Coverage for Over-the-Counter Contraceptives
News ReleaseWith federal regulators seeking public input on the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover over-the-counter preventive products without a prescription, a new KFF post explores the issues relevant to covering over-the-counter contraceptives.
-
Considerations for Covering Over-the-Counter Contraception
Policy WatchIn October 2023, the Departments of the Treasury, Labor, and Health and Human Services issued a request for information to gather public input about the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover OTC preventive services and supplies without a prescription. This policy watch addresses key considerations for the implementation of insurance coverage for non-prescribed OTC contraceptives based on the lessons learned from KFF’s 2023 study of Insurance Coverage of OTC Oral Contraceptives.
-
KFF Examines How Abortion Bans, Misinformation, and State Actions May Affect Access to Contraception
News ReleaseFollowing the Supreme Court’s ruling overturning Roe v. Wade, uncertainty has emerged over whether the right to contraception could also be limited.
-
Addressing Misinformation in Rural Communities: Snapshot from the KFF Health Misinformation Tracking Poll Pilot
Poll FindingThis report examines the exposure to, and belief in, health misinformation among people living in rural communities, as well as the media sources they use and the trust they place in health information received from various outlets. It is a companion to the KFF Health Misinformation Tracking Poll Pilot.
-
KFF Examines Challenges in Navigating Coverage for Opill, the First Over-the-Counter Daily Oral Contraceptive Pill, Coming to Market Next Year
News ReleaseAs Opill—the first over-the-counter daily oral contraceptive pill in the United States—is expected to be available for purchase in early 2024, new research conducted by KFF examines barriers to its accessibility for consumers and challenges in providing insurance coverage for it.